These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 12902992)
21. Chronic buprenorphine reduces the response to sucrose-associated cues in non food-deprived rats. Hood S; Sorge RE; Stewart J Pharmacol Biochem Behav; 2007 Mar; 86(3):566-75. PubMed ID: 17346785 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of an injection depot formulation of buprenorphine: placebo comparison. Sigmon SC; Wong CJ; Chausmer AL; Liebson IA; Bigelow GE Addiction; 2004 Nov; 99(11):1439-49. PubMed ID: 15500597 [TBL] [Abstract][Full Text] [Related]
23. Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects. Gerra G; Zaimovic A; Raggi MA; Moi G; Branchi B; Moroni M; Brambilla F Psychiatry Res; 2007 Jan; 149(1-3):201-13. PubMed ID: 17129610 [TBL] [Abstract][Full Text] [Related]
24. Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats. Burke NN; Ferdousi M; Deaver DR; Finn DP; Roche M; Kelly JP Neuropharmacology; 2019 Mar; 146():327-336. PubMed ID: 30553825 [TBL] [Abstract][Full Text] [Related]
25. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240 [TBL] [Abstract][Full Text] [Related]
26. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine. Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647 [TBL] [Abstract][Full Text] [Related]
27. Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. Pathak S; Vince B; Kelsh D; Shram MJ; Setnik B; Lu H; Nangia N; Stanford AD; Ehrich E J Clin Pharmacol; 2019 Feb; 59(2):206-217. PubMed ID: 30102427 [TBL] [Abstract][Full Text] [Related]
28. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887 [TBL] [Abstract][Full Text] [Related]
29. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B; Christoph T; Strassburger W; Friderichs E Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189 [TBL] [Abstract][Full Text] [Related]
30. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. Matson SC; Hobson G; Abdel-Rasoul M; Bonny AE J Addict Med; 2014; 8(3):176-82. PubMed ID: 24695018 [TBL] [Abstract][Full Text] [Related]